†
471
HR 5005 EAS
(2) by striking ‘‘chapter or a regulation pre-
scribed under this chapter.’’ in subsection (a)(2) and
inserting ‘‘chapter, a regulation prescribed under this
chapter, or a hazardous materials transportation se-
curity regulation or directive issued by the Secretary
of Homeland Security.’’; and
(3) by striking ‘‘chapter or a regulation pre-
scribed under this chapter,’’ in subsection (b)(1) and
inserting ‘‘chapter, a regulation prescribed under this
chapter, or a hazardous materials transportation se-
curity regulation or directive issued by the Secretary
of Homeland Security,’’.
SEC. 1712. OFFICE OF SCIENCE AND TECHNOLOGY POLICY.
The National Science and Technology Policy, Organi-
zation, and Priorities Act of 1976 is amended—
(1) in section 204(b)(1) (42 U.S.C. 6613(b)(1)),
by inserting ‘‘homeland security,’’ after ‘‘national se-
curity,’’; and
(2) in section 208(a)(1) (42 U.S.C. 6617(a)(1)),
by inserting ‘‘the Office of Homeland Security,’’ after
‘‘National Security Council,’’.
†
472
HR 5005 EAS
SEC. 1713. NATIONAL OCEANOGRAPHIC PARTNERSHIP PRO-
GRAM.
Section 7902(b) of title 10, United States Code, is
amended by adding at the end the following new para-
graphs:
‘‘(13) The Under Secretary for Science and Tech-
nology of the Department of Homeland Security.
‘‘(14) Other Federal officials the Council con-
siders appropriate.’’.
SEC. 1714. CLARIFICATION OF DEFINITION OF MANUFAC-
TURER.
Section 2133(3) of the Public Health Service Act (42
U.S.C. 300aa–33(3)) is amended—
(1) in the first sentence, by striking ‘‘under its
label any vaccine set forth in the Vaccine Injury
Table’’ and inserting ‘‘any vaccine set forth in the
Vaccine Injury table, including any component or in-
gredient of any such vaccine’’; and
(2) in the second sentence, by inserting ‘‘includ-
ing any component or ingredient of any such vac-
cine’’ before the period.
SEC. 1715. CLARIFICATION OF DEFINITION OF VACCINE-RE-
LATED INJURY OR DEATH.
Section 2133(5) of the Public Health Service Act (42
U.S.C. 300aa–33(5)) is amended by adding at the end the
following: ‘‘For purposes of the preceding sentence, an
†
473
HR 5005 EAS
adulterant or contaminant shall not include any component
or ingredient listed in a vaccine’s product license applica-
tion or product label.’’.
SEC. 1716. CLARIFICATION OF DEFINITION OF VACCINE.
Section 2133 of the Public Health Service Act (42
U.S.C. 300aa–33) is amended by adding at the end the fol-
lowing:
‘‘(7) The term ‘vaccine’ means any preparation
or suspension, including but not limited to a prepa-
ration or suspension containing an attenuated or in-
active microorganism or subunit thereof or toxin, de-
veloped or administered to produce or enhance the
body’s immune response to a disease or diseases and
includes all components and ingredients listed in the
vaccines’s product license application and product
label.’’.
SEC. 1717. EFFECTIVE DATE.
The amendments made by sections 1714, 1715, and
1716 shall apply to all actions or proceedings pending on
or after the date of enactment of this Act, unless a court
of competent jurisdiction has entered judgment (regardless
†
474
HR 5005 EAS
of whether the time for appeal has expired) in such action
or proceeding disposing of the entire action or proceeding.
Attest:
Secretary.